Most are familiar with the name Moderna and its landmark role in developing one of the first COVID-19 vaccines, but few know how the company leveraged AI to accelerate its creation. Today, Moderna’s Director of AI and Data Science, Dr. Andrew Giessel, joins us on The ConversAItion to discuss how his team leverages AI to accelerate the mRNA research process for a number of different applications, the importance of training employees in AI basics and how computer science and biology can work hand-in-hand in the future to transform the pharmaceutical industry. You can find Andrew on Twitter @giessel.
How Josh.ai Powers Truly Smart Homes
Pinterest Powers Content Personalization with AI
How AI & Automation Power Remote Learning
1-800-Flowers.com Leverages AI as Business Blooms
Adam Oliner: How AI Keeps Companies Connected At Home
Dave Touretzky: Teaching Kids AI in School
Elan Mosbacher: SpotHero Brings AI to Parking
Tomas Chamorro-Premuzic: Unlocking Employee Potential with AI
Alexandra Deschamps-Sonsino: Smarter Homes with IoT
Michael Littman: Humanity-Centered Robotics
Louis Rosenberg: Making Groups Smarter with AI
Karen Hao: Reporting on AI Amid COVID-19
Thomas Arnold: Ethical Human-Robot Interactions
Tom Davenport: AI & the Future of Work
Jim Kennelly: AI & Voice in Entertainment
Susse Jensen: Voice & Designing for Inclusivity
Gabriel Skantze: Social Robots & the Uncanny Valley
Rob Atkinson: AI Adoption & the Innovation Cycle
Create your
podcast in
minutes
It is Free
Insight Story: Tech Trends Unpacked
Zero-Shot
Fast Forward by Tomorrow Unlocked: Tech past, tech future
The Unbelivable Truth - Series 1 - 26 including specials and pilot
Lex Fridman Podcast